Hemodynamic Optimization Through Pleth Variability Index for OHCA

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

September 1, 2023

Study Completion Date

September 30, 2023

Conditions
Cardiac Arrest With Successful Resuscitation
Interventions
DEVICE

Pleth variability index

The utility of a early goal directed therapy will be evaluate by the pleth variability index (PVI). If above\>13% in a well sedated patients perfectly synchronized with the ventilator providing at least 6ml/kg of ideal body weight, a fluid challeng with 10ml/kg of NaCl 0,9% will be administrated. Patient will be constantly re-assessed until the hemodynamic goals of a mean arterial pressure above 65 mmHg, a capillary refill time below 3 seconds, a decreasing trend on lactates and a urinary output above 0.5/ml/kg/h will be achieved. The second fluid challenge will always be performed with 100 ml of albumin 20%. The third fluid challenge if necessary will be performed with 10 ml/kg of NaCl 0.9%.

DEVICE

Standard non invasive monitoring

In the control group patients will be hemodynamically resuscitated in the early phases after ROSC based on standard non invasive monitoring such as SatO2, EtCO2, non invasive blood pressure and continuous ECG. If deemed necessary by the treating physician a fluid challenge of 10ml/kg of NaCl 0,9% will be administrated. Patient will be constantly re-assessed until the hemodynamic goals of a mean arterial pressure above 65 mmHg, a capillary refill time below 3 seconds, a decreasing trend on lactates and a urinary output above 0.5/ml/kg/h will be achieved. The second fluid challenge will always be performed with 100 ml of albumin 20%. The third fluid challenge if necessary will be performed with 10 ml/kg of NaCl 0.9%.

Trial Locations (1)

1000

CHU Saint Pierre, Brussels

All Listed Sponsors
collaborator

Andre Vesale Association

UNKNOWN

lead

Stefano Malinverni, MD

OTHER

NCT03841708 - Hemodynamic Optimization Through Pleth Variability Index for OHCA | Biotech Hunter | Biotech Hunter